| 24th Apr 2018 7:00 am |
RNS |
AstraZeneca:high level results of the ARCTIC trial |
| 24th Apr 2018 7:00 am |
RNS |
Issue of Equity - AstraZeneca |
| 19th Apr 2018 7:00 am |
RNS |
FDA approves Tagrisso for 1st-line use in NSCLC |
| 13th Apr 2018 11:00 am |
RNS |
Notice of AGM |
| 5th Apr 2018 7:00 am |
RNS |
Directorate Change |
| 3rd Apr 2018 3:00 pm |
RNS |
Total Voting Rights |
| 3rd Apr 2018 7:00 am |
RNS |
FDA TO REVIEW MOXETUMOMAB FOR HAIRY CELL LEUKAEMIA |
| 3rd Apr 2018 7:00 am |
RNS |
AZ AND MSD SUBMIT LYNPARZA FOR BREAST CANCER IN EU |
| 28th Mar 2018 3:00 pm |
RNS |
Director/PDMR Shareholding |
| 26th Mar 2018 3:00 pm |
RNS |
Director/PDMR Shareholding |
| 22nd Mar 2018 4:48 pm |
RNS |
Lokelma approved in the EU |
| 12th Mar 2018 7:00 am |
RNS |
ASTRAZENECA UPDATES MYSTIC TRIAL TIMELINE |
| 7th Mar 2018 7:00 am |
RNS |
Filing of Form 20-F with SEC |
| 6th Mar 2018 11:00 am |
RNS |
Annual Financial Report |
| 1st Mar 2018 3:00 pm |
RNS |
Total Voting Rights |
| 23rd Feb 2018 12:35 pm |
RNS |
Lynparza CHMP for ovarian cancer maintainance |
| 19th Feb 2018 7:00 am |
RNS |
AstraZeneca's IMFINZI approved for Stage III nsclc |
| 15th Feb 2018 7:00 am |
RNS |
Selumetinib in NF1 gets FDA orphan drug status |
| 5th Feb 2018 2:00 pm |
RNS |
Director/PDMR Shareholding |
| 2nd Feb 2018 7:00 am |
RNS |
AZN: Full-Year 2017 Results |
| 1st Feb 2018 3:00 pm |
RNS |
Total Voting Rights |
| 26th Jan 2018 6:20 pm |
RNS |
AZ Reports Phase III Results for PT010 in COPD |
| 26th Jan 2018 7:00 am |
RNS |
AZ Reports Phase III Results for PT010 in COPD |
| 19th Jan 2018 7:00 am |
RNS |
ASTRAZENECA'S FASENRA RECEIVES APPROVAL IN JAPAN |
| 19th Jan 2018 7:00 am |
RNS |
LYNPARZA APPROVED IN JAPAN FOR OVARIAN CANCER |
| 12th Jan 2018 4:10 pm |
RNS |
FDA approves Lynparza for metastatic breast cancer |
| 10th Jan 2018 3:10 pm |
RNS |
AstraZeneca's Fasenra approved in the EU |
| 2nd Jan 2018 3:00 pm |
RNS |
Total Voting Rights |
| 28th Dec 2017 2:00 pm |
RNS |
Director/PDMR Shareholding |
| 18th Dec 2017 7:00 am |
RNS |
FDA accepts Tagrisso submission for 1st-line nsclc |
| 15th Dec 2017 12:00 pm |
RNS |
Director/PDMR Shareholding |
| 1st Dec 2017 3:00 pm |
RNS |
Block listing Interim Review |
| 1st Dec 2017 3:00 pm |
RNS |
Total Voting Rights |
| 28th Nov 2017 7:00 am |
RNS |
EMA accepts Tagrisso submission for 1st-line nsclc |
| 27th Nov 2017 7:00 am |
RNS |
AZ submits Tagrisso in Japan for 1st-line nsclc |
| 15th Nov 2017 7:00 am |
RNS |
AZ Fasenra receives FDA approval for severe asthma |
| 10th Nov 2017 11:35 am |
RNS |
BENRALIZUMAB POSITIVE CHMP IN EOSINOPHILIC ASTHMA |
| 9th Nov 2017 7:00 am |
RNS |
AZN: Year-To-Date and Q3 2017 Results Announcement |
| 1st Nov 2017 3:00 pm |
RNS |
Total Voting Rights |
| 1st Nov 2017 7:03 am |
RNS |
ASTRAZENECA AND ASPEN COMPLETE ANAESTHETICS DEAL |
